Thomas Delong

educated at: University of Erlangen–Nuremberg

occupation: researcher

Series

There is nothing here

Create a new serie

Works

There is nothing here

Create a new work

Articles 9

Date

Title

Authors

2019-01-03

Identification of Hybrid Insulin Peptides (HIPs) in Mouse and Human Islets by Mass Spectrometry

Timothy Wiles, Roger Powell, Cole Michel, K. Scott Beard, Anita Hohenstein, Brenda Bradley, Nichole Reisdorph, Kathryn Haskins, Thomas Delong
2019-06-17

HIPs and HIP-reactive T cells

Timothy Wiles, Thomas Delong
2019-06-07

Hybrid Insulin Peptides Are Autoantigens in Type 1 Diabetes

Rocky Lee Baker, Aaron W. Michels, Kathryn Haskins, Thomas Delong
2016-02-01

Pathogenic CD4 T cells in type 1 diabetes recognize epitopes formed by peptide fusion

Timothy Wiles, Rocky Lee Baker, Brenda Bradley, Thomas Delong, Kathryn Haskins
2015-11-25

Cutting Edge: Nonobese Diabetic Mice Deficient in Chromogranin A Are Protected from Autoimmune Diabetes

Rocky Lee Baker, Timothy Wiles, Robin S Lindsay, Robert S Lindsay, Brenda Bradley, Thomas Delong, Kathryn Haskins
2013-09-16

Cutting edge: CD4 T cells reactive to an islet amyloid polypeptide peptide accumulate in the pancreas and contribute to disease pathogenesis in nonobese diabetic mice

Rocky Lee Baker, Brenda Bradley, Thomas Delong, Kathryn Haskins
2012-08-21

Diabetogenic T-cell clones recognize an altered peptide of chromogranin A.

Brenda Bradley, Thomas Delong, Kathryn Haskins
2011-07-06

Islet amyloid polypeptide is a target antigen for diabetogenic CD4+ T cells

Brenda Bradley, Thomas Delong, Kathryn Haskins
2010-03

Chromogranin A is an autoantigen in type 1 diabetes

Philippa Marrack, John Kappler, Brenda Bradley, Brian D Stadinski, Nichole Reisdorph, Richard Reisdorph, Roger Powell, Kathryn Haskins, Thomas Delong

Human - wd:Q90749876

Welcome to Inventaire

the library of your friends and communities

learn more